作者
樊 婷,栗海龙
文章摘要
肝脏富血供肿瘤是临床工作中的一类常见肿瘤,目前该组肿瘤影像学诊断的重点和难点在于其早期的诊断及其良恶性的鉴别诊断。近年来随着能谱CT新型检查技术的广泛应用,提高了该组肿瘤的检出率及诊断率,对于临床治疗决策的制定和改善患者预后的意义极其重大。因此本文将从能谱CT的技术原理及其近年来在肝脏富血供肿瘤中的研究进展进行综述。
文章关键词
肝脏富血供肿瘤;能谱CT;肝癌;肝血管瘤;富血供肝转移瘤
参考文献
[1] MILETO A,MARIN D,NELSON R C,et al.Dual energy MDCT assessment of renal lesions:an overview[J].Eur Radiol,2014,24(2):353-362.
[2] NAKAYAMA Y,AWAI K,FUNAMA Y,et al.Abdominal CT with low tube voltage:preliminary observations about radiation dose,contrast enhancement,image quality,and noise[J].Radiology,2005,237(3):945-951.
[3] MARIN D,NELSON R C,SAMEI E,et al.Hypervascular liver tumors:low tube voltage,high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience[J].Radiology,2009,251(3):771-779.
[4] KALRA M K,MAHER M M,BLAKE M A,et al.Detection and characterization of lesions on low-radiation-dose abdominal CT images postprocessed with noise reduction filters[J].Radiology,2004,232(3):791-797.
[5] MARIN D,BOLL D T,MILETO A,et al.State of the art:dual-energy CT of the abdomen[J].Radiology,2014,271(2):327-342.
[6] NOURIAN A,GHIRALDI E,FRIEDLANDER J I.Dual-Energy CT for Urinary Stone Evaluation[J].Curr Urol Rep,2020,22(1):1.
[7] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.
[8] ZHENG Z,MEI J,GUAN R,et al.A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy[J].Cancer Immunol Immunother,2024,73(8):158.
[9] ELSAYES K M,HOOKER J C,AGRONS M M,et al.2017 Version of LI-RADS for CT and MR Imaging:An Update[J].Radiographics,2017,37(7):1994-2017.
[10] YOO J,LEE J M,YOON J H,et al.Comparison of low kVp CT and dual-energy CT for the evaluation of hypervascular hepatocellular carcinoma[J].Abdom Radiol(NY),2021,46(7):3217-3226.
[11] LAROIA S T,BHADORIA A S,VENIGALLA Y,et al.Role of dual energy spectral computed tomography in characterization of hepatocellular carcinoma:Initial experience from a tertiary liver care institute[J].Eur J Radiol Open,2016,3:162-171.
[12] YAMAGUCHI H,ICHIKAWA T,MORISAKA H,et al.Early detection of hypervascularization in hepatocellular carcinoma(≤2 cm)on hepatic arterial phase with virtual monochromatic imaging:Comparison with low-tube voltage CT[J].Medicine(Baltimore),2023,102(39):e34774.
[13] LV P,LIU J,YAN X,et al.CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours[J].Eur Radiol,2017,27(3):918-926.
[14] DAI X,SCHLEMMER H P,SCHMIDT B,et al.Quantitative therapy response assessment by volumetric iodine-uptake measurement:initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib[J].Eur J Radiol,2013,82(2):327-334.
[15] THAISS W M,HABERLAND U,KAUFMANN S,et al.Iodine concentration as a perfusion surrogate marker in oncology:Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp[J].Eur Radiol,2016,26(9):2929-2936.
[16] LAROIA S T,YADAV K,KUMAR S,et al.Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver:a retrospective study[J].Eur Radiol Exp,2021,5(1):22.
[17] ISIK B,GONULTAS F,SAHIN T,et al.Microvascular Venous Invasion in Hepatocellular Carcinoma:Why Do Recurrences Occur?[J].J Gastrointest Cancer,2020,51(4):1133-1136.
[18] ZHANG E L,CHENG Q,HUANG Z Y,et al.Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion[J].Front Oncol,2021,11:691354.
[19] ZHU Y,FENG B,CAI W,et al.Prediction of Microvascular Invasion in Solitary AFP-Negative Hepatocellular Carcinoma≤5 cm Using a Combination of Imaging Features and Quantitative Dual-Layer Spectral-Detector CT Parameters[J].Acad Radiol,2023,30 Suppl 1:S104-S116.
[20] 甘郑宁,马梦雪,严小娟.能谱CT成像碘物质定量分析在肝细胞癌鉴别诊断中的应用价值[J].肝脏,2020,25(07):695-698.
[21] 岳倩倩,王新怡,杨志强,等.富血供肝脏转移瘤与肝细胞肝癌的能谱CT成像定量分析[J].山东大学学报(医学版),2016,54(07):50-55.
[22] LI W,LI R,ZHAO X,et al.Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging[J].J Clin Transl Hepatol,2021,9(3):315-323.
[23] YU Y,LIN X,CHEN K,et al.Hepatocellular carcinoma and focal nodular hyperplasia of the liver:differentiation with CT spectral imaging[J].Eur Radiol,2013,23(6):1660-1668.
Full Text:
DOI